Researchers at the University of California San Diego performed the world's first surgical procedures using teleoperated humanoid robots on living animals. Two Unitree G1 humanoids removed gallbladders from live pigs in a preclinical trial published on July 9, 2026 in Nature. The results show that a commercially available, comparatively affordable humanoid robot can — with the right modifications — serve as a teleoperation platform inside an operating room.
Key takeaways
- Unitree G1 humanoids (weight: 27 kg, height: 1.27 m) performed laparoscopic cholecystectomies on two live pigs
- Study published in Nature (July 9, 2026) — the first such publication on humanoid surgical robotics
- Base price of Unitree G1: approx. $13,500 — a fraction of the da Vinci system (~$500K–$3M+)
- Surgeries took longer than with specialized systems, partly due to repeated recalibrations
- The long-term goal is to enable remote surgery in small hospitals, rural areas, and battlefield conditions
A humanoid in the operating room
The project goes by the working name "Surgie." Surgeons operated from a console with a stereoscopic display and a foot pedal to engage or disengage hand movements. To allow the robot to hold surgical instruments, engineers built custom mechanical adapters and software that maps natural hand motions to precise tool movements at the robot's wrists.
The first surgery included a human assistant standing beside the robot. The second — more advanced — used two teleoperated humanoids working together simultaneously, without a human at the operating table.
Where the Unitree G1 falls short of da Vinci
Comparing "Surgie" to the market-leading da Vinci system from Intuitive Surgical reveals clear gaps. Da Vinci is FDA-cleared, validated in numerous clinical trials, and used routinely worldwide. It weighs around 800 kg and occupies substantial floor space, but it is precisely optimized for surgery. Unitree G1 has an arm span of just 450 mm — far below an adult human's reach. Both operations required several minutes of pauses for recalibration of robot position and tool alignment. Latency between operator motion and robot response measured in the hundreds of milliseconds, while research suggests remote surgical robots should operate below 150 ms to be clinically safe.
Despite these limitations, the economics are compelling. A G1 with dexterous hands costs under $70,000 — a fraction of the da Vinci price tag, which can run into several million dollars and requires specialized infrastructure.
Teleoperation, not autonomy
The distinction is critical: "Surgie" is a teleoperation system, not an autonomous one. A surgeon remains in the decision loop at all times. Michael Yip of UC San Diego, a co-lead on the project, points to an autonomous surgical assistant as the long-term target — a machine that could handle routine sub-tasks under physician supervision.
Experts broadly agree that full autonomous surgical capability remains far off. Too much depends on haptic perception, situational context, and reaction speed — areas where current AI systems have only partial mastery.
Why this matters
The San Diego results open a new direction in medical robotics. Specialized systems like da Vinci are too expensive and too large to reach every district hospital or field clinic. A Unitree G1-class humanoid — with the right adapters — can be transported, set up, and operated remotely in locations where a patient today simply has no access to a surgeon.
This does not mean the Unitree G1 is ready for clinical use. Latency, limited arm reach, and the need for frequent recalibration are real barriers. But a study published in Nature is a serious validation milestone, not just a demo. The operation succeeded, proving the concept is feasible. That shifts the question from "is this possible" to "how long until it is safe."
The surgical robotics market is growing fast — industry data suggest it will exceed $20 billion by 2030. It has long been dominated by expensive, dedicated systems. If humanoid teleoperation platforms prove clinically safe, they could create an entirely new category: accessible remote surgery.
What's next?
- The UC San Diego team plans to iterate on software to reduce latency and improve motion accuracy toward the 150 ms threshold required for safe remote surgery
- Additional preclinical studies and — eventually — human clinical trials are required before any regulatory approval pathway (FDA or EMA) can be pursued
- Unitree continues to upgrade the G1 platform — next-generation dexterous hands may lower the barrier for similar research projects
Sources
- Ars Technica — Humanoid robots controlled by surgeons did world-first operation on live pigs
- Nature — Teleoperated humanoid robot surgery (primary publication)
- UC San Diego Today — press release
